Biomarker panels for prognosis prediction in heart failure on a CHARM basis

As in other medicine fields, science in heart failure is discovering and testing more biomarkers for prognostic use. The natriuretic peptides and troponins—the most cardiac specific of the present biomarkers—have proved useful biomarkers for predicting cardiac events in heart failure patients, on top of established and validated clinical prediction markers (1,2).